Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) Consolidated Net Income (2016 - 2026)

Bioceres Crop Solutions' Consolidated Net Income history spans 5 years, with the latest figure at -$14.1 million for Q1 2026.

  • On a quarterly basis, Consolidated Net Income fell 261.54% to -$14.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$18.0 million, a 44.46% decrease, with the full-year FY2025 number at -$58.8 million, down 907.32% from a year prior.
  • Consolidated Net Income hit -$14.1 million in Q1 2026 for Bioceres Crop Solutions, down from -$3.9 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for BIOX hit a ceiling of -$3.9 million in Q1 2025 and a floor of -$14.1 million in Q1 2026.
  • Historically, Consolidated Net Income has averaged -$8.9 million across 3 years, with a median of -$8.6 million in 2022.
  • Biggest five-year swings in Consolidated Net Income: crashed 182.04% in 2022 and later tumbled 261.54% in 2026.
  • Tracing BIOX's Consolidated Net Income over 3 years: stood at -$8.6 million in 2022, then surged by 54.44% to -$3.9 million in 2025, then tumbled by 261.54% to -$14.1 million in 2026.
  • Business Quant data shows Consolidated Net Income for BIOX at -$14.1 million in Q1 2026, -$3.9 million in Q1 2025, and -$8.6 million in Q2 2022.